Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 30;14(1):166.
doi: 10.3390/nu14010166.

Gut Microbiota and Complications of Type-2 Diabetes

Affiliations
Review

Gut Microbiota and Complications of Type-2 Diabetes

Camelia Oana Iatcu et al. Nutrients. .

Abstract

The gut microbiota has been linked to the emergence of obesity, metabolic syndrome and the onset of type 2 diabetes through decreased glucose tolerance and insulin resistance. Uncontrolled diabetes can lead to serious health consequences such as impaired kidney function, blindness, stroke, myocardial infarction and lower limb amputation. Despite a variety of treatments currently available, cases of diabetes and resulting complications are on the rise. One promising new approach to diabetes focuses on modulating the gut microbiota with probiotics, prebiotics, synbiotics and fecal microbial transplantation. Differences in gut microbiota composition have been observed in preclinical animal models as well as patients with type 2 diabetes and complications such as diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, cerebrovascular disease, coronary heart disease and peripheral artery disease compared to healthy controls. Severity of gut microbiota dysbiosis was associated with disease severity and restoration with probiotic administration in animal models and human patients has been associated with improvement of symptoms and disease progression. Characterizing the gut microbiota dysbiosis in different diseases and determining a causal relationship between the gut microbiota and disease can be beneficial in formulating therapeutic interventions for type 2 diabetes and associated complications. In this review, we present the most important findings regarding the role of the gut microbiota in type 2 diabetes and chronic complications as well as their underlying mechanisms.

Keywords: diabetes complications; gut microbiota dysbiosis; macrovascular complications; microvascular complications; nephropathies; retinopathies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic view of the link between gut microbiota, diabetes and chronic complications of diabetes. The left side panel depicts chronic micro- and macrovascular complications of diabetes, and associated changes in the composition of the gut microbiota. Poorly controlled diabetes leads to chronic complications over time, and dysbiosis of the gut microbiota seems to promote the onset and progression of these complications. The right panel depicts the potential effects of restoring gut microbiota eubiosis in ameliorating, preventing or delaying the onset of chronic complications of diabetes, via probiotics, prebiotics, symbiotics or by fecal microbiota transplantation. ↑, increase; ↓, decrease.

References

    1. D’Argenio V., Salvatore F. The role of the gut microbiome in the healthy adult status. Clin. Chim. Acta. 2015;451:97–102. doi: 10.1016/j.cca.2015.01.003. - DOI - PubMed
    1. Matijasic M., Mestrovic T., Paljetak H.C., Peric M., Baresic A., Verbanac D. Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD. Int. J. Mol. Sci. 2020;21:2668. doi: 10.3390/ijms21082668. - DOI - PMC - PubMed
    1. Jayasudha R., Das T., Kalyana Chakravarthy S., Sai Prashanthi G., Bhargava A., Tyagi M., Rani P.K., Pappuru R.R., Shivaji S. Gut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy. PLoS ONE. 2020;15:e0243077. doi: 10.1371/journal.pone.0243077. - DOI - PMC - PubMed
    1. Mazloom K., Siddiqi I., Covasa M. Probiotics: How Effective Are They in the Fight against Obesity? Nutrients. 2019;11:258. doi: 10.3390/nu11020258. - DOI - PMC - PubMed
    1. Mar Rodriguez M., Perez D., Javier Chaves F., Esteve E., Marin-Garcia P., Xifra G., Vendrell J., Jove M., Pamplona R., Ricart W., et al. Obesity changes the human gut mycobiome. Sci. Rep. 2015;5:14600. doi: 10.1038/srep14600. - DOI - PMC - PubMed

MeSH terms